Leading investors and experts will discuss the outlook and opportunities for investors and entrepreneurs in six areas of health and medicine.

Obesity & Metabolic Disorders. This panel will discuss a broad range of prophylactic and interventional strategies for bringing new therapies to obesity-related patient care.

Diagnostics & Personalized Medicine. This panel will explore the changing world of diagnostics, focusing on the product areas and business models that have made this such a hot area for investors.

Neurology. This panel will discuss basic science, development costs, regulation, and IP rights, along with an exploration of scenarios for new neurological product development.

Cardiology. This panel of experienced medical and business professionals will describe what is on the cardiac care horizon.

Oncology. This panel will discuss oncological product development in the context of recent changes in financial markets, regulatory processes, and IP law.

Ophthalmology. This panel of financial experts will focus on investment opportunities, IP protection, and market strategies in ophthalmologic health care.

Its unique format of sector-oriented panel discussions, company presentations and investor meetings is designed to connect CEOs with appropriate institutional, venture and private investors.